Andrew Lotery

28.8k total citations · 5 hit papers
310 papers, 11.1k citations indexed

About

Andrew Lotery is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Andrew Lotery has authored 310 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 250 papers in Ophthalmology, 164 papers in Radiology, Nuclear Medicine and Imaging and 110 papers in Molecular Biology. Recurrent topics in Andrew Lotery's work include Retinal Diseases and Treatments (214 papers), Retinal Imaging and Analysis (136 papers) and Retinal Development and Disorders (92 papers). Andrew Lotery is often cited by papers focused on Retinal Diseases and Treatments (214 papers), Retinal Imaging and Analysis (136 papers) and Retinal Development and Disorders (92 papers). Andrew Lotery collaborates with scholars based in United Kingdom, United States and Germany. Andrew Lotery's co-authors include Susan M. Downes, Usha Chakravarthy, Simon Harding, Maria Gemenetzi, Barnaby C Reeves, Chris Rogers, Sobha Sivaprasad, Sam Khandhadia, Edwin M. Stone and J. Arjuna Ratnayaka and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Andrew Lotery

298 papers receiving 10.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration

2012 626 citations Usha Chakravarthy, Chris Rogers et al. Ophthalmology profile →
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial

2014 622 citations Andrew Lotery et al. profile →
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

2013 575 citations Usha Chakravarthy, Chris Rogers et al. profile →
Central serous chorioretinopathy: Towards an evidence-based treatment guideline

2019 314 citations Elon H. C. van Dijk, Suzanne Yzer et al. profile →
Defining response to anti-VEGF therapies in neovascular AMD

2015 262 citations Usha Chakravarthy, Andrew Lotery et al. Eye profile →

Peers

Countries citing papers authored by Andrew Lotery

Since Specialization

Citations

This map shows the geographic impact of Andrew Lotery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Lotery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Lotery more than expected).

Fields of papers citing papers by Andrew Lotery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Lotery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Lotery. The network helps show where Andrew Lotery may publish in the future.

Co-authorship network of co-authors of Andrew Lotery

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Lotery. A scholar is included among the top collaborators of Andrew Lotery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Lotery. Andrew Lotery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long term analysis of microbiological isolates and antibiotic susceptibilities in acute-onset postoperative endophthalmitis: a UK multicentre study 2025 ·Eye ·(unknown), Ariel Yuhan Ong, (unknown), (unknown), C. Settle, Andrew Lotery, Peter Charbel Issa, Jonathan Smith, David Steel	0
2	Dual pathway inhibition with faricimab for previously treated neovascular age-related macular degeneration and diabetic macular oedema: guidance from a UK panel of retina specialists 2024 ·Eye ·Louise Downey, Sobha Sivaprasad, (unknown), Clare Bailey, (unknown), Samer Elsherbiny, Jignesh Patel, Giuliana Silvestri, (unknown), (unknown), (unknown), (unknown), Andrew Lotery	4
3	Deep Learning–Based Clustering of OCT Images for Biomarker Discovery in Age-Related Macular Degeneration (PINNACLE Study Report 4) 2024 ·Ophthalmology Science ·Robbie Holland, Rebecca Kaye, Ahmed M. Hagag, (unknown), Thomas R. Taylor, Hrvoje Bogunović, Ursula Schmidt‐Erfurth, Hendrik P. N. Scholl, Daniel Rueckert, Andrew Lotery, Sobha Sivaprasad, Martin J. Menten	3
4	Comparison of Novel Volumetric Microperimetry Metrics in Intermediate Age-Related Macular Degeneration: PINNACLE Study Report 3 2023 ·Translational Vision Science & Technology ·(unknown), Ghislaine L. Traber, Maximilian Pfau, Sophie Riedl, Ahmed M. Hagag, (unknown), Julia Mai, Rebecca Kaye, Hrvoje Bogunović, Lars G. Fritsche, Daniel Rueckert, Ursula Schmidt‐Erfurth, Sobha Sivaprasad, Andrew Lotery, Hendrik P. N. Scholl	2
5	A laser-induced mouse model of progressive retinal degeneration with central sparing displays features of parafoveal geographic atrophy 2023 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), J. Arjuna Ratnayaka, Jessica L. Teeling, Andrew Lotery	5
6	Associations with baseline visual acuity in 12,414 eyes starting treatment for neovascular AMD 2022 ·Eye ·Samuel D. Relton, (unknown), Andrew Lotery, Robert West, (unknown), (unknown), (unknown), Clare Bailey, (unknown), Peter H. Scanlon, Louise Downey, (unknown), (unknown), (unknown), (unknown), (unknown), Martin McKibbin	2
7	Deep Learning Prediction Of Age And Sex From Optical Coherence Tomography 2021 ·(unknown), Martin J. Menten, Hrvoje Bogunović, Ursula Schmidt‐Erfurth, Andrew Lotery, Daniel Rueckert	7
8	The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients 2021 ·Open Research Europe ·(unknown), Philipp T. Möller, Camiel J.F. Boon, Andrew Lotery, Philipp Herrmann, Maurízio Battaglia Parodi, (unknown), Mario G. Fsadni, Thomas H. Wheeler‐Schilling, (unknown), H. Konrad Muller, Frank G. Holz, Steffen Schmitz-Valckenberg, Tobias Peters, Katarína Štingl, Carel B. Hoyng	7
9	Eplerenone versus placebo for chronic central serous chorioretinopathy: the VICI RCT 2021 ·SHILAP Revista de lepidopterología ·Andrew Lotery, Sobha Sivaprasad, Abby O’Connell, Rosie A Harris, Lucy Culliford, Angela J. Cree, Savita Madhusudhan, Helen Griffiths, Lucy Ellis, Usha Chakravarthy, Tünde Pető, Chris Rogers, Barnaby C Reeves	8
10	Socioeconomic risk factors and age-related macular degeneration in the UK Biobank study 2021 ·BMJ Open Ophthalmology ·Jennifer Yip, Zaynah Muthy, Tünde Pető, Andrew Lotery, Paul J. Foster, Praveen J. Patel	17
11	Association of ambient air pollution with age-related macular degeneration and retinal thickness in UK Biobank 2021 ·British Journal of Ophthalmology ·Sharon Chua, Alasdair Warwick, Tünde Pető, Konstantinos Balaskas, Anthony T. Moore, Charles Reisman, Parul Desai, Andrew Lotery, Baljean Dhillon, Peng T. Khaw, Christopher G. Owen, Anthony P. Khawaja, Paul J. Foster, Praveen J. Patel	53
12	Oligomeric Aβ1-42 Induces an AMD-Like Phenotype and Accumulates in Lysosomes to Impair RPE Function 2021 ·Cells ·(unknown), David A. Johnston, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Dillon Davis, (unknown), David S. Chatelet, Anton Page, Angela J. Cree, Helena Lee, Tracey A. Newman, Andrew Lotery, J. Arjuna Ratnayaka	12
13	Quantification of Key Retinal Features in Early and Late Age-Related Macular Degeneration Using Deep Learning 2021 ·American Journal of Ophthalmology ·Bart Liefers, Paul Taylor, (unknown), Clare Bailey, Konstantinos Balaskas, Narendra Dhingra, Catherine Egan, (unknown), Cristina González-Gonzalo, Tjebo Heeren, Andrew Lotery, Philipp L. Müller, Abraham Olvera‐Barrios, Bobby Paul, Roy Schwartz, (unknown), Alasdair Warwick, Adnan Tufail, Clara I. Sá‎nchez	47
14	Modelling Sorsby’s Fundus Dystrophy using patient-derived iPSC-RPE 2019 ·Investigative Ophthalmology & Visual Science ·(unknown), David R. Christensen, Heidi Hongisto, (unknown), (unknown), Angela J. Cree, Heli Skottman, J. Arjuna Ratnayaka, Andrew Lotery	1
15	Discrepancy in current central serous chorioretinopathy classification 2018 ·British Journal of Ophthalmology ·Sumit Randhir Singh, Alexandre Matet, Elon H. C. van Dijk, Alejandra Daruich, Sascha Fauser, Suzanne Yzer, Enrico Peiretti, Sobha Sivaprasad, Andrew Lotery, Camiel J. F. Boon, Francine Béhar‐Cohen, K. Bailey Freund, Jay Chhablani	47
16	Lysosomal impairment in the Retinal Pigment Epithelium (RPE) - a pathway of damage in the ageing retina 2018 ·Investigative Ophthalmology & Visual Science ·(unknown), David A. Johnston, David S. Chatelet, David A. Tumbarello, Andrew Lotery, J. Arjuna Ratnayaka	1
17	United Kingdom multicenter Medisoft™ electronic medical record real-world audit following implant of ILUVIEN® (fluocinolone acetonide 190 µg) – the first 3-year results from the UK 2018 ·Investigative Ophthalmology & Visual Science ·Fahd Quhill, Clare Bailey, Usha Chakravarthy, Andrew Lotery, Geeta Menon, James Talks	2
18	Associations with Retinal Pigment Epithelium Thickness Measures in a Large Cohort 2016 ·Ophthalmology ·Fang Ko, Paul J. Foster, Nicholas G. Strouthidis, Yusrah Shweikh, Qi Yang, Charles Reisman, Zaynah Muthy, Usha Chakravarthy, Andrew Lotery, Pearse A. Keane, Adnan Tufail, Carlota M. Grossi, Praveen J. Patel	56
19	Genome-wide association study of primary open angle glaucoma risk and quantitative traits. 2012 ·PubMed ·Jane Whitney Gibson, Helen Griffiths, Gabriella De Salvo, (unknown), A. Jacob, Alex MacLeod, Yit C. Yang, Geeta Menon, Angela J. Cree, Sarah Ennis, Andrew Lotery	33
20	Prevalence of Mutations in the RPE65, CRX, AIPL1, TULP1, GUCY2D and CRB1 Genes in Leber Congenital Amaurosis 2003 ·Investigative Ophthalmology & Visual Science ·Andrew Lotery, Samuel G. Jacobson, Richard G. Weleber, Alessandro Iannaccone, (unknown), G. A. Fishman, A. Levin, Byron L. Lam, Elise Héon, Edwin M. Stone	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact